Skin Diseases  >>  iniparib (BSI 201)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
iniparib (BSI 201) / Sanofi
NCT00938652: A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer

Checkmark In pts with metastatic TNBC
Oct 2014 - Oct 2014: In pts with metastatic TNBC
Checkmark P3 data (TNBC)
Jan 2012 - Jan 2012: P3 data (TNBC)
Checkmark Data
More
Completed
3
519
US
gemcitabine/carboplatin, Iniparib, BSI-201, SAR240550
Sanofi
Breast Cancer
01/11
02/12

Download Options